{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:28:02Z","timestamp":1760549282632},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/2008-2231-20-93","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T13:14:26Z","timestamp":1355404466000},"source":"Crossref","is-referenced-by-count":18,"title":["Chitosan and chitosan chlorhydrate based various approaches for enhancement of dissolution rate of carvedilol"],"prefix":"10.1186","volume":"20","author":[{"given":"Amol S","family":"Shete","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adhikrao V","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa M","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"key":"87_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpharm.2011.05.070","volume":"415","author":"H Xi","year":"2011","unstructured":"Xi H, Chinmay G, Daniel T, Yuhua C, Dave R: Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles. Int J Pharm. 2011, 415: 185-195. 10.1016\/j.ijpharm.2011.05.070.","journal-title":"Int J Pharm"},{"key":"87_CR2","first-page":"18","volume":"8","author":"A Nokhodchi","year":"2005","unstructured":"Nokhodchi A: The effect of type and concentration of vehicle on dissolution rate of poorly water soluble drug (indomethacin) from liquid solid compacts. J Pharm Pharmaceut Sci. 2005, 8: 18-25.","journal-title":"J Pharm Pharmaceut Sci"},{"key":"87_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.colsurfb.2011.06.020","volume":"88","author":"M Kakran","year":"2011","unstructured":"Kakran M, Sahoo NG, Li L: Dissolution enhancement of quercetin through nanofabrication, complexation, and solid dispersion. Colloids Surf B: Biointerfaces. 2011, 88: 121-130. 10.1016\/j.colsurfb.2011.06.020.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"87_CR4","volume-title":"Drug Dev Ind Pharm","author":"FA Andre","year":"2012","unstructured":"Andre FA, Bruno GG, Chris V, Jean Paul R: Gelucire 44\/14 based immediate release formulations for poorly water-soluble drugs. Drug Dev Ind Pharm. 2012, 10.3109\/03639045.2012.709251. Posted online on August 8"},{"key":"87_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","volume":"59","author":"N Blagden","year":"2007","unstructured":"Blagden N, de Matas M, Gavan P, York P: Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deli Rev. 2007, 59: 617-630. 10.1016\/j.addr.2007.05.011.","journal-title":"Adv Drug Deli Rev"},{"key":"87_CR6","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1021\/cg200492w","volume":"11","author":"N Jagadeesh Babu","year":"2011","unstructured":"Jagadeesh Babu N, Nangia A: Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Crystal Growth & Design. 2011, 11: 2662-10.1021\/cg200492w.","journal-title":"Crystal Growth & Design"},{"key":"87_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v29.i3.10","volume":"29","author":"R Chadha","year":"2012","unstructured":"Chadha R, Saini A, Arora P, Bhandari S: Pharmaceutical cocrystals: A novel approach for oral bioavailability enhancement of drugs. Crit Rev Ther Drug Carrier Syst. 2012, 29: 183-218. 10.1615\/CritRevTherDrugCarrierSyst.v29.i3.10.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"87_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3109\/03639049809089942","volume":"24","author":"O Felt","year":"1998","unstructured":"Felt O, Buri P, Gurny R: Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 1998, 24: 979-993. 10.3109\/03639049809089942.","journal-title":"Drug Dev Ind Pharm"},{"key":"87_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ijpharm.2011.12.010","volume":"423","author":"D Nicolas","year":"2012","unstructured":"Nicolas D, Julien R, Raphael R, Pierre G, Jean-Marc S, Christine J, Jean-Fran\u00e7ois G, V\u00e9ronique P: Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs. Int J Pharm. 2012, 423: 452-460. 10.1016\/j.ijpharm.2011.12.010.","journal-title":"Int J Pharm"},{"key":"87_CR10","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay P, Mishra R, Rana D, Kundu P: Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review. Prog Polym Sci. Available online 16 May 2012 In Press, Corrected Proof","DOI":"10.1016\/j.progpolymsci.2012.04.004"},{"key":"87_CR11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-780950-2.50008-3","volume-title":"Chitin, Chitosan and Related Enzymes","author":"T Nagai","year":"1984","unstructured":"Nagai T, Sawayanagi Y, Nambu N: Applications of chitin and chitosan to pHarmaceutical preparations. Chitin, Chitosan and Related Enzymes. Edited by: Zizakis JP. 1984, Orlando, FL: Academic Press, 21-39."},{"key":"87_CR12","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3109\/03639049409050225","volume":"20","author":"GC Ritthidej","year":"1994","unstructured":"Ritthidej GC, Chomto P, Pummangura S, Menasveta P: Chitin and chitosan as disintegrants in paracetamol tablets. Drug Dev Ind Pharm. 1994, 20: 2109-2134. 10.3109\/03639049409050225.","journal-title":"Drug Dev Ind Pharm"},{"key":"87_CR13","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3109\/03639049209040896","volume":"18","author":"SM Upadrashta","year":"1992","unstructured":"Upadrashta SM, Katikaneni PR, Nuessle NO: Chitosan as a tablet binder. Drug Dev Ind PHarm. 1992, 18: 1701-1708. 10.3109\/03639049209040896.","journal-title":"Drug Dev Ind PHarm"},{"key":"87_CR14","first-page":"2062","volume":"31","author":"Y Sawayanagi","year":"1983","unstructured":"Sawayanagi Y, Nambu N, Nagai T: Dissolution properties and bioavailability of pHenytoin from ground mixtures with chitin or chitosan. Chem Pharm Bull. 1983, 31: 2062-2068.","journal-title":"Chem Pharm Bull"},{"key":"87_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1248\/cpb.38.185","volume":"38","author":"S Shiraishi","year":"1990","unstructured":"Shiraishi S, Arahira M, Imai T, Otagiri M: Enhancement of dissolution rates of several drugs by low molecular chitosan and alginate. Chem Pharm Bull. 1990, 38: 185-187. 10.1248\/cpb.38.185.","journal-title":"Chem Pharm Bull"},{"key":"87_CR16","first-page":"605","volume":"48","author":"F Acarturk","year":"1993","unstructured":"Acarturk F, Sencan A, Celebi N: Evaluation of the effect of low molecular weight chitosan on the solubility and dissolution characteristics of spironolactone. Pharmazie. 1993, 48: 605-607.","journal-title":"Pharmazie"},{"key":"87_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-5173(98)00245-2","volume":"175","author":"A Portero","year":"1998","unstructured":"Portero A, Remun\u00e3n-Lopez C, Vila-Jato JL: Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine. Int J Pharm. 1998, 175: 75-84. 10.1016\/S0378-5173(98)00245-2.","journal-title":"Int J Pharm"},{"key":"87_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0169-409X(00)00130-7","volume":"46","author":"D Horter","year":"2001","unstructured":"Horter D, Dressman JB: Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deli Rev. 2001, 46: 75-87. 10.1016\/S0169-409X(00)00130-7.","journal-title":"Adv Drug Deli Rev"},{"key":"87_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijpharm.2004.11.015","volume":"290","author":"AK Anal","year":"2005","unstructured":"Anal AK, Stevens WF: Chitosan\u2013alginate multilayer beads for controlled release of ampicillin. Int J Pharm. 2005, 290: 45-54. 10.1016\/j.ijpharm.2004.11.015.","journal-title":"Int J Pharm"},{"key":"87_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijpharm.2007.09.006","volume":"350","author":"S Mutalik","year":"2008","unstructured":"Mutalik S, Prambil A, Krishnan M, Achuta NU: Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan based solvent change approach. Int J Pharm. 2008, 350: 279-90. 10.1016\/j.ijpharm.2007.09.006.","journal-title":"Int J Pharm"},{"key":"87_CR21","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1208\/s12249-010-9441-9","volume":"11","author":"R Talari","year":"2010","unstructured":"Talari R, Varshosaz J, Abolfazl Mostafavi S, Nokhodchi A: Gliclazide microcrystals prepared by two methods of in situ micronization: pharmacokinetic studies in diabetic and normal rats. AAPS PharmTech. 2010, 11: 786-792. 10.1208\/s12249-010-9441-9.","journal-title":"AAPS PharmTech"},{"key":"87_CR22","volume-title":"Pharm Dev Technol","author":"NA Ahmed","year":"2011","unstructured":"Ahmed NA, Viviane FN, Safaa S: Formulation and physicochemical characterization of chitosan\/Acyclovir co-crystals. Pharm Dev Technol. 2011"},{"key":"87_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0928-0987(03)00068-X","volume":"19","author":"P Mura","year":"2003","unstructured":"Mura P, Zerrouk N, Mennini N, Maestrelli F, Chemtob C: Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties. Eur J Pharm Sci. 2003, 19: 67-75. 10.1016\/S0928-0987(03)00068-X.","journal-title":"Eur J Pharm Sci"},{"key":"87_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ijpharm.2003.11.024","volume":"271","author":"F Maestrelli","year":"2004","unstructured":"Maestrelli F, Zerrouk N, Chemtob C, Mura P: Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Int J Pharm. 2004, 271: 257-267. 10.1016\/j.ijpharm.2003.11.024.","journal-title":"Int J Pharm"},{"key":"87_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1248\/cpb.54.1650","volume":"54","author":"VSG Kumar","year":"2006","unstructured":"Kumar VSG, Mishra DN: Preparation characterization and in vitro dissolution studies of solid systems of valdecoxib with chitosan. Chem Pharm Bull. 2006, 54: 2-12.","journal-title":"Chem Pharm Bull"},{"key":"87_CR26","volume-title":"Handbook of PHarmaceutical excipients","author":"RC Rowe","year":"2006","unstructured":"Rowe RC, Sheskey PJ, Owen SC: Handbook of PHarmaceutical excipients. 2006, London, United Kingdom: PHarmaceutical Press"},{"key":"87_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijpharm.2004.09.007","volume":"288","author":"M Perrut","year":"2005","unstructured":"Perrut M, Jung J, Leboeuf F: Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I. Micronization of neat particles. Int J Pharm. 2005, 288: 3-10. 10.1016\/j.ijpharm.2004.09.007.","journal-title":"Int J Pharm"},{"key":"87_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/0250-474X.41470","volume":"70","author":"BD Shewale","year":"2008","unstructured":"Shewale BD, Sapkal NA, Raut NJ, Gaikwad RA: Effect of hydroxy propyl B- Cyclodextrin on solubility of carvedilol. Indian J PHarm Sci. 2008, 70: 255-257. 10.4103\/0250-474X.41470.","journal-title":"Indian J PHarm Sci"},{"key":"87_CR29","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3109\/03639049109048059","volume":"17","author":"PS Adusumilli","year":"1991","unstructured":"Adusumilli PS, Bolton SM: Evaluation of chitosan citrate complexes as matrices for controlled release formulations using a 32 full factorial design. Drug Dev Ind PHarm. 1991, 17: 1931-1945. 10.3109\/03639049109048059.","journal-title":"Drug Dev Ind PHarm"},{"key":"87_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0378-5173(91)90260-U","volume":"67","author":"T Imai","year":"1991","unstructured":"Imai T, Shiraishi S, Saito H, Otagiri M: Interaction of indomethacin with low-molecular weight chitosan and improvement of some pHarmaceutical properties of indomethacin by low-molecular weight chitosans. Int J Pharm. 1991, 67: 11-20. 10.1016\/0378-5173(91)90260-U.","journal-title":"Int J Pharm"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2008-2231-20-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2008-2231-20-93\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2008-2231-20-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T20:46:33Z","timestamp":1568666793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/2008-2231-20-93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1186\/2008-2231-20-93","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"93"}}